GLP-1 Research
When you stop taking Ozempic, research shows most people regain significant weight within a year — here's why…
Research shows semaglutide can cause significant muscle loss alongside fat loss — here's what the science says about…
A 2025 peer-reviewed analysis of GLP-1 medications explicitly recommends creatine monohydrate for preserving lean muscle during weight loss…
Ozempic doesn't interact with most drugs through the liver enzyme pathways you'd expect — but its effect on…
Semaglutide causes measurable muscle loss in clinical studies, but resistance training and strategic protein intake can largely offset…
Semaglutide works by mimicking the GLP-1 hormone to suppress appetite, stabilize blood sugar, and drive fat loss —…
Emerging research published in JAMA Neurology, JAMA Psychiatry, and Alzheimer's Research & Therapy reveals that GLP-1 receptor agonists…
Injecting Ozempic into muscle instead of subcutaneous fat alters the drug's absorption rate and increases the risk of…
A 2025 meta-analysis reveals that roughly 25% of weight lost on semaglutide and tirzepatide comes from lean mass…
Ozempic's active ingredient semaglutide is a GLP-1 receptor agonist with robust clinical evidence behind it — here's exactly…